25 related articles for article (PubMed ID: 3259891)
1. Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin.
Brito-Babapulle F; Huang D; Lavender P; Galton D; Catovsky D
Eur J Haematol; 1988 Feb; 40(2):185-7. PubMed ID: 3257929
[TBL] [Abstract][Full Text] [Related]
2. Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia.
el'Agnaf MR; Ennis KE; Morris TC; Robertson JH; Markey G; Alexander HD
Br J Haematol; 1986 May; 63(1):93-104. PubMed ID: 2939873
[TBL] [Abstract][Full Text] [Related]
3. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
Kefford RF; Fox RM
Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
[TBL] [Abstract][Full Text] [Related]
4. Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.
Dearden CE; Matutes E; Hoffbrand AV; Ganeshaguru K; Brozovic M; Williams HJ; Traub N; Mills M; Linch DC; Catovsky D
Br Med J (Clin Res Ed); 1987 Oct; 295(6603):873-5. PubMed ID: 2890401
[TBL] [Abstract][Full Text] [Related]
5. T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin).
Spiers AS; Davis MP; Levine M; Li CY; Mangan KF; Mazza JJ; Neu LT; O'Brien J; Rauch AE; Wiltsie JC
Scand J Haematol; 1985 Jan; 34(1):57-67. PubMed ID: 2578689
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous presentation of prolymphocytic leukaemia.
Logan RA; Smith NP
Br J Dermatol; 1988 Apr; 118(4):553-8. PubMed ID: 3259891
[TBL] [Abstract][Full Text] [Related]
7. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
[TBL] [Abstract][Full Text] [Related]
8. Perspectives in the treatment of hairy cell leukemia.
Debusscher L; Stryckmans P
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1095-7. PubMed ID: 3308481
[No Abstract] [Full Text] [Related]
9. 2'-deoxycoformycin. A new anticancer agent.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
[TBL] [Abstract][Full Text] [Related]
10. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
Parkinson DR; Mier JW
Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
[No Abstract] [Full Text] [Related]
12. Mirror-image lesions in cutaneous malignancies.
Ellerin BE; Nisce LZ; Nori D
Int J Dermatol; 2000 Mar; 39(3):171-7. PubMed ID: 10759953
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
